The MDS-ES 2nd Summer School on Neuromodulation for Movement Disorders took place in Würzburg, Germany on September 6-8, 2018. The workshop was excellently directed by Professors Elena Moro and Jens Volkmann, with the collaboration of faculties of different countries, particularly from the Würzburg University. The course was held in a lovely and quiet building, the Burkardushaus Würzburg, in the heart of the city.

The latest CME article October 2018: “European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus” is online! Please log-in and browse… Continue Reading

Please find below articles from Turkish authors and co-authors that were published in the European Journal of Neurology

The Sixty-eight session of the World Health Organisation Regional Committee for Europe took place in Rome, Italy (16 – 20 September, 2018).                   Health ministers and high-level representatives of the 53 Member States… Continue Reading

Alshimaa Othman, MD, Cairo, Egypt Term of the stay: 16.4. – 28.9.2018 Hosting department:
Department of Neuroscience. Neurology Unit, Nuovo Ospedale Civile Sant’Agostino Estense,
via Giardini, 1355, 41126 Modena, Italy Supervisor : Prof. Stefano Meletti I would like to express… Continue Reading

How do you see the role of the Communication Committee (CC) within the overall work of the EAN? In principle, communication is at the basis of the functioning of a society, both within, and with partners or the various publics. The main communicators of a society are its president, the members of the board and, the executive director. The CC is more a think tank, an initiator, a follow-upper, and a workhorse tackling all the various communication agenda.

How do you see the role of the Education Committee within the overall work of EAN? Prof. Hannah Cock (HC): Education is fundamental to the vision of EAN. Education underpins the sharing of knowledge and excellence. It also forms a substantial part of the annual congress, and offers numerous other opportunities to bring members together including our regular schools and other teaching courses and e-learning resources.

Prof Gunhild Waldemar (GW): Prof. Winblad, from EADC’s point of view, how is the research into dementia and Alzheimer’s Disease in particular, highlighted or addressed in the Swedish national dementia strategy launched so recently? Will it positively influence the ongoing research? Prof. Bengt Winblad (BW): Sweden launched a ”National Dementia Strategy” May 24, 2018. A general disappointment was that one of the countries leading much of research in care, epidemiology, clinical and basic research did not even produce a Dementia Plan like the other Scandinavian countries and most other EU countries.

EAN and Wiley want to know how neurology is making a difference, and how it has inspired you.
Tell us and you could win an iPad Pro!   All you need to do is post your tweets, photos, videos and… Continue Reading

During 2017, EFNA continued their patient empowerment work through their Training Initiatives for Neurology Advocates (TINA), which grew to incorporate one pan-European event in Brussels and three national workshops in Bucharest, Valencia and Warsaw. These covered a wide variety of… Continue Reading

The European Medicines Agency (EMA) is launching a new version of its corporate website for the HCPWP – Health Care Professional Working Party of which EAN is a partner, www.ema.europa.eu, on Thursday 27 September.
The new website will help us… Continue Reading

        by Anna Sauerbier         “Love your brain campaign”
https://2018.ecnp.eu/programme/Love_Your_Brain.aspx   Hope – and a welter of concerns – greets Europe’s radical open access plan
https://sciencebusiness.net/news/hope-and-welter-concerns-greets-europes-radical-open-access-plan   Bill Gates announces $30 Million investment to… Continue Reading

On 21 November 2018, the European Brain Council, together with its industry partners, hosts the event “Enhanced engagement through public-private partnerships: Sustaining therapeutic innovation to address patient needs” as part of its Value of Innovation series.

Our 2018 General Assembly will take place on November 21, in Brussels, the agenda is currently in development.       The statutory General Assembly will take place during the morning session and we will propose the mission adaptation of… Continue Reading